A RANDOMIZED PHASE 2 TRIAL OF CEDIRANIB IN COMBINATION WITH OLAPARIB VERSUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Arrillaga-Romany, I; Sahebjam, S; Picconi, D; Campian, J; Giglio, P; Drappatz, J; Aiken, R; Villano, J; Lee, E; Welch, M; Ellingson, B; Ney, D; Becker, K; Muzikansky, A; Das, B; Swisher, E; Nixon, A; Karlovich, C; Williams, PM; Ivy, SP; Batchelor, T; Gerstner, E

Published Date

  • November 1, 2019

Published In

Volume / Issue

  • 21 /

Start / End Page

  • 27 - 27

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1523-5866

International Standard Serial Number (ISSN)

  • 1522-8517

Conference Name

  • 24th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Conference Location

  • Phoenix, AZ

Conference Start Date

  • November 20, 2019

Conference End Date

  • November 24, 2019